Based on SEC filing data. A biotech corporation in New Haven, CT that has raised $2.3 million in equity seed funding. The company is in the early development stage.
Get notified the moment Osmol Therapeutics, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.